BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10461063)

  • 1. Hypermethylation of the p16 gene in sporadic T3N0M0 stage colorectal cancers: association with DNA replication error and shorter survival.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Wu MS; Wang SM; Lin JT; Cheng AL
    Oncology; 1999; 57(2):149-56. PubMed ID: 10461063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
    Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
    Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of p16INK4a by CpG hypermethylation is not a frequent event in colorectal cancer.
    Norrie MW; Hawkins NJ; Todd AV; Meagher AP; O'Connor TW; Ward RL
    J Surg Oncol; 2003 Nov; 84(3):143-50. PubMed ID: 14598358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRAS, BRAF oncogene mutations and tissue specific promoter hypermethylation of tumor suppressor SFRP2, DAPK1, MGMT, HIC1 and p16 genes in colorectal cancer patients.
    Bagci B; Sari M; Karadayi K; Turan M; Ozdemir O; Bagci G
    Cancer Biomark; 2016 Jun; 17(2):133-43. PubMed ID: 27540971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A; Conte D; Frattini M; Zaffaroni N; Andriani F; Balestra D; Tavecchio L; Daidone MG; Sozzi G
    Clin Cancer Res; 2002 Dec; 8(12):3782-7. PubMed ID: 12473590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer.
    Vlaykova T; Mitkova A; Stancheva G; Kadiyska T; Gulubova M; Yovchev Y; Cirovski G; Chilingirov P; Damyanov D; Kremensky I; Mitev V; Kaneva R
    J BUON; 2011; 16(2):265-73. PubMed ID: 21766496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
    Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
    Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypermethylation of the CDKN2A gene in colorectal cancer is associated with shorter survival.
    Maeda K; Kawakami K; Ishida Y; Ishiguro K; Omura K; Watanabe G
    Oncol Rep; 2003; 10(4):935-8. PubMed ID: 12792748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation profile of promoter region of p16 gene in colorectal cancer patients of Kashmir valley.
    Wani HA; Beigh MA; Amin S; Bhat AA; Bhat S; Khan H; Mattoo AA; Showkat M; Masood A; Majid S
    J Biol Regul Homeost Agents; 2013; 27(2):297-307. PubMed ID: 23830381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
    Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
    Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
    Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential frequencies of p16(INK4a) promoter hypermethylation, p53 mutation, and K-ras mutation in exfoliative material mark the development of lung cancer in symptomatic chronic smokers.
    Kersting M; Friedl C; Kraus A; Behn M; Pankow W; Schuermann M
    J Clin Oncol; 2000 Sep; 18(18):3221-9. PubMed ID: 10986054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Goto T; Mizukami H; Shirahata A; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
    Anticancer Res; 2009 Jan; 29(1):275-7. PubMed ID: 19331161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic characterization of colorectal cancers in young patients based on chromosomal loss and microsatellite instability.
    Tada T; Watanabe T; Kanazawa T; Kazama S; Koketsu S; Nagawa H
    Scand J Gastroenterol; 2004 Nov; 39(11):1134-40. PubMed ID: 15545173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis.
    Esteller M; Toyota M; Sanchez-Cespedes M; Capella G; Peinado MA; Watkins DN; Issa JP; Sidransky D; Baylin SB; Herman JG
    Cancer Res; 2000 May; 60(9):2368-71. PubMed ID: 10811111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of the p16 gene and loss of its protein expression is correlated with tumor progression in extrahepatic bile duct carcinomas.
    Hong SM; Choi J; Ryu K; Ro JY; Yu E
    Arch Pathol Lab Med; 2006 Jan; 130(1):33-8. PubMed ID: 16390235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Replication error in colorectal carcinoma: association with loss of heterozygosity at mismatch repair loci and clinicopathological variables.
    Johannsdottir JT; Bergthorsson JT; Gretarsdottir S; Kristjansson AK; Ragnarsson G; Jonasson JG; Egilsson V; Ingvarsson S
    Anticancer Res; 1999; 19(3A):1821-6. PubMed ID: 10470121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of DNA methylation status analyzed by bisulfite-PCR-SSCP and correlation with clinico-pathological characteristics in colorectal cancer.
    Maekawa M; Sugano K; Ushiama M; Fukayama N; Nomoto K; Kashiwabara H; Fujita S; Kakizoe T
    Clin Chem Lab Med; 2001 Feb; 39(2):121-8. PubMed ID: 11341745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
    Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
    Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.